Crossref journal-article
American Association for the Advancement of Science (AAAS)
Science (221)
Abstract

Recurrent chromosomal rearrangements have not been well characterized in common carcinomas. We used a bioinformatics approach to discover candidate oncogenic chromosomal aberrations on the basis of outlier gene expression. Two ETS transcription factors, ERG and ETV1 , were identified as outliers in prostate cancer. We identified recurrent gene fusions of the 5′ untranslated region of TMPRSS2 to ERG or ETV1 in prostate cancer tissues with outlier expression. By using fluorescence in situ hybridization, we demonstrated that 23 of 29 prostate cancer samples harbor rearrangements in ERG or ETV1 . Cell line experiments suggest that the androgen-responsive promoter elements of TMPRSS2 mediate the overexpression of ETS family members in prostate cancer. These results have implications in the development of carcinomas and the molecular diagnosis and treatment of prostate cancer.

Bibliography

Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., Lee, C., Montie, J. E., Shah, R. B., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2005). Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer. Science, 310(5748), 644–648.

Authors 16
  1. Scott A. Tomlins (first)
  2. Daniel R. Rhodes (additional)
  3. Sven Perner (additional)
  4. Saravana M. Dhanasekaran (additional)
  5. Rohit Mehra (additional)
  6. Xiao-Wei Sun (additional)
  7. Sooryanarayana Varambally (additional)
  8. Xuhong Cao (additional)
  9. Joelle Tchinda (additional)
  10. Rainer Kuefer (additional)
  11. Charles Lee (additional)
  12. James E. Montie (additional)
  13. Rajal B. Shah (additional)
  14. Kenneth J. Pienta (additional)
  15. Mark A. Rubin (additional)
  16. Arul M. Chinnaiyan (additional)
References 35 Referenced 3,219
  1. 10.1038/35106108
  2. 10.1038/372143a0
  3. 10.1038/243290a0
  4. 10.1038/300765a0
  5. 10.1182/blood-2004-08-3097
  6. 10.1016/S1383-5742(00)00006-5
  7. Materials and methods are available as supporting material on Science Online.
  8. 10.1016/S1476-5586(04)80047-2
  9. 10.1038/nrc1299
  10. Detailed results from the application of COPA to Oncomine data sets can be explored at www.oncomine.org.
  11. 10.1016/S0378-1119(02)01156-3
  12. 10.1002/jcb.20012
  13. I. S. Jeon et al., Oncogene10, 1229 (1995). / Oncogene (1995)
  14. 10.1038/ng0294-146
  15. 10.1073/pnas.0304146101
  16. 10.1172/JCI20032
  17. 10.1158/0008-5472.CAN-03-2876
  18. B. Lin et al., Cancer Res.59, 4180 (1999). / Cancer Res. (1999)
  19. D. E. Afar et al., Cancer Res.61, 1686 (2001). / Cancer Res. (2001)
  20. 10.1046/j.1432-1327.2001.02165.x
  21. 10.1038/sj.onc.1208518
  22. 10.3322/canjclin.55.1.10
  23. 10.1056/NEJMoa040465
  24. 10.1073/pnas.1131754100
  25. 10.1182/blood-2003-01-0338
  26. 10.1056/NEJMoa030847
  27. S. M. Dhanasekaran et al., FASEB J.19, 243 (2005). / FASEB J. (2005)
  28. J. B. Welsh et al., Cancer Res.61, 5974 (2001). / Cancer Res. (2001)
  29. 10.1182/blood.V99.5.1745
  30. 10.1038/35090585
  31. 10.1016/S0140-6736(03)13308-9
  32. 10.1073/pnas.1732912100
  33. 10.1016/S0140-6736(02)08270-3
  34. 10.1200/JCO.2004.05.158
  35. We thank D. Roulston and E. Fearon for helpful discussions D. Robins and K. Burnstein for the PC3+AR cells and R. Desphande and C. Creighton for technical assistance. Supported by the Early Detection Research Network Biomarker Developmental Lab UO1 CA111275-01 (to A.M.C.); NIH Prostate specialized program of research excellence (SPORE) P50CA69568 (to K.J.P) RO1 CA97063 (to A.M.C.) and R01AG21404 (to M.A.R.); American Cancer Society RSG-02-179-MGO (to A.M.C.); Department of Defense (PC040517 to R.M. and PC020322 to A.M.C.); and the Cancer Center Bioinformatics Core (support grant 5P30 CA46592). D.R.R. is supported by the Cancer Biology Training Program. K.J.P. is an American Cancer Society Clinical Research Professor. A.M.C. is a Pew Biomedical Scholar and S.A.T. and D.R.R. are Fellows of the Medical Scientist Training Program. Nucleotide sequences for the TMPRSS2:ETS fusions have been deposited at GenBank with accession numbers DQ204770 to DQ04773.
Dates
Type When
Created 19 years, 10 months ago (Oct. 27, 2005, 6:38 p.m.)
Deposited 1 year, 7 months ago (Jan. 9, 2024, 8:54 p.m.)
Indexed 2 days, 1 hour ago (Aug. 31, 2025, 6:27 a.m.)
Issued 19 years, 10 months ago (Oct. 28, 2005)
Published 19 years, 10 months ago (Oct. 28, 2005)
Published Print 19 years, 10 months ago (Oct. 28, 2005)
Funders 0

None

@article{Tomlins_2005, title={Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer}, volume={310}, ISSN={1095-9203}, url={http://dx.doi.org/10.1126/science.1117679}, DOI={10.1126/science.1117679}, number={5748}, journal={Science}, publisher={American Association for the Advancement of Science (AAAS)}, author={Tomlins, Scott A. and Rhodes, Daniel R. and Perner, Sven and Dhanasekaran, Saravana M. and Mehra, Rohit and Sun, Xiao-Wei and Varambally, Sooryanarayana and Cao, Xuhong and Tchinda, Joelle and Kuefer, Rainer and Lee, Charles and Montie, James E. and Shah, Rajal B. and Pienta, Kenneth J. and Rubin, Mark A. and Chinnaiyan, Arul M.}, year={2005}, month=oct, pages={644–648} }